Prognos is a leading provider of actionable clinical and genomic laboratory data, leveraging over 12 years of experience to integrate and enrich lab data from more than 20 sources. The company focuses on unlocking the potential of laboratory data to enhance health outcomes by offering a comprehensive data marketplace. This marketplace allows users to build, manage, and apply transactional record-level data efficiently, facilitating access to de-identified patient data that includes lab results, prescriptions, and medical claims. Prognos emphasizes the importance of harmonizing this data at scale to provide unique insights across various therapeutic areas, ultimately supporting improved patient outcomes and accelerating the development of innovative therapies.

The technologies employed by Prognos enable healthcare stakeholders to access high-fidelity, ready-to-use clinical and genomic data that can complement existing datasets or serve as a comprehensive solution for commercial analytics strategies. Their offerings include tools for cohort design, physician segmentation, and omnichannel marketing, all aimed at enhancing the precision and effectiveness of healthcare interventions. By utilizing a token from their partner Datavant, Prognos facilitates the integration of diverse data sources, ensuring that clients have the specific insights they need without the burden of excessive data procurement. This approach not only streamlines data access but also accelerates the time to insight, allowing for more targeted and timely healthcare interventions.

United States

Prognos Health is a real-world data (RWD) company that unlocks the power of data to improve health. Prognos offers the leading managed RWD marketplace, accelerating the development and delivery of innovative therapies and improving health outcomes by offering fully integrated and harmonized lab and health records on more than 325 million de-identified patients. Prognos Health's platform provides a comprehensive and integrated view of patient health, enabling researchers, payers, and providers to make better decisions about care.

Prognos

Company Details